Vaccine developer Varnotech has secured 600 million yuan ($84 million) in a Series B funding round co-led by Beijing Pharmaceutical and Healthcare Industry Investment Fund, a 20-billion-yuan ($2.8 billion) fund set up by Beijing State-owned Capital Operation and Management Company.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
